A phase I/II randomized, double-blind, placebo-controlled pilot study of beta-D-2,6-diaminopurine dioxolane (DAPD) [amdoxovir] versus DAPD plus mycophenolate mofetil in treatment-experienced patients.

Trial Profile

A phase I/II randomized, double-blind, placebo-controlled pilot study of beta-D-2,6-diaminopurine dioxolane (DAPD) [amdoxovir] versus DAPD plus mycophenolate mofetil in treatment-experienced patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 May 2012

At a glance

  • Drugs Amdoxovir (Primary) ; Mycophenolate mofetil (Primary)
  • Indications HIV infections; HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top